The CDC revised its US Medical Eligibility Criteria for Contraceptive Use categorization for DMPA injection in women at high risk for HIV infection from US MEC category 1 to US MEC category 2.
More than half of women receiving a new HIV diagnosis have already received this diagnosis in the past but are not undergoing HIV medical care.
Consensus regarding mammography screening varies, and conflicting guidelines from medical organizations can cause confusion for patients and providers.
Among women, but not men, mid-adulthood hypertension correlated with a 65% increased dementia risk.
Duration of total and exclusive breastfeeding was significantly associated with a decreased risk of endometriosis.
A variety of non-hormone options and therapies are available for treatment of estrogen-depletion symptoms and clinical problems after a diagnosis of breast cancer.
Overall, 54% of women with bipolar disorder reported sexual distress and 39% were not satisfied with their sexual life.
Early diagnosis and treatment play a substantial role in a patient's prognosis and result in a decreased risk of malignancy and scarring.
The standard treatment option for premenopausal women who do not wish to get pregnant is hysterectomy.
The prevalence of COPD globally is increasing more rapidly in women than in men.
The largest increase in reported STD cases occurred in P&S syphilis, gonorrhea and chlamydia.
Women who use hormonal contraception have an increased risk for first use of an antidepressant and first diagnosis of depression.
Screening for asymptomatic bacteriuria may not lead to better outcomes among pregnant women and exposes them to unnecessary antibiotics.
LGBT practice management includes routine cancer screening in accordance with current guidelines.
50% of women studied met the American Cancer Society requirements for early mammography screening.
In an update to its 2009 recommendations, the U.S. Preventive Services Task Force has presented its final guidelines on mammography screening for breast cancer.
Couples conceiving within the 0- to 3-month interval are more likely to achieve live birth.
Denosumab may reduce the risk of fracture in women with breast cancer on aromatase inhibitor therapyJanuary 06, 2016
Denosumab has been shown to reduce fracture risk in women with breast cancer with bone metastases.
Vitamin D deficiency is especially prevalent in postmenopausal women, and recommendations from current guidelines are inconsistent regarding vitamin D use.
Starting January 1, the state of Oregon no longer requires a prescription for birth control for women 18 years of age and older.
For women who are pro-life advocates, copper IUD devices that prevent fertilization may be an acceptable alternative.
Confusion surrounds the current screening recommendations and guidelines.
False-positive results on a screening mammogram are associated with a greater risk of developing breast cancer in the 10 years following the result.
Correctly position your patient to ensure a proper Pap smear.
A new study of women with at least 2 risk factors for breast cancer found that ultrasound and mammography have similar breast cancer detection rates.
The ACOG issued new guidelines for cervical cancer screening, recommending that screening start at age 21.
In a study of over 278,000 patients with stage 1 through stage 3 breast cancer, African American women had the lowest rate of pathologic complete response.
Researchers found 512 incident and 478 recurrent fibroid cases in patients with high testosterone and high estradiol.
Researchers confirmed increased risks for infertility and natural menopause before age 50 in women who are either active smokers or regularly exposed to secondhand smoke.
ACOG's current recommendations regarding Pap smear testing for cervical cancer may be the best evidence-based practice for patients.